» Articles » PMID: 28943103

Lower Vertebrate and Invertebrate Models of Alzheimer's Disease - A Review

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2017 Sep 26
PMID 28943103
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is a common neurodegenerative disorder which is characterized by the presence of beta- amyloid protein and neurofibrillary tangles (NFTs) in the brain. Till now, various higher vertebrate models have been in use to study the pathophysiology of this disease. But, these models possess some limitations like ethical restrictions, high cost, difficult maintenance of large quantity and lesser reproducibility. Besides, various lower chordate animals like Danio rerio, Drosophila melanogaster, Caenorhabditis elegans and Ciona intestinalis have been proved to be an important model for the in vivo determination of targets of drugs with least limitations. In this article, we reviewed different studies conducted on theses models for the better understanding of the pathophysiology of AD and their subsequent application as a potential tool in the preclinical evaluation of new drugs.

Citing Articles

Neuroprotective Effect of Extract in Scopolamine-Induced Cognitive Impairment in Rats: Behavioral and Biochemical Approaches.

Lazarova M, Stefanova M, Denev P, Taseva T, Vassileva V, Tasheva K Biology (Basel). 2024; 13(6).

PMID: 38927306 PMC: 11201232. DOI: 10.3390/biology13060426.


extracts confer neuroprotective effect in model of Alzheimer's disease by attenuating amyloid-β aggregation and toxicity.

Kleawyothatis W, Jattujan P, Chumphoochai K, Chalorak P, Sobhon P, Meemon K J Tradit Complement Med. 2023; 13(1):93-104.

PMID: 36685078 PMC: 9845652. DOI: 10.1016/j.jtcme.2022.10.006.


Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model.

Anand A, Khurana N, Ali N, Alasmari A, Alharbi M, Waseem M Front Neurosci. 2022; 16:1005972.

PMID: 36408377 PMC: 9672091. DOI: 10.3389/fnins.2022.1005972.


A Critical Review of Zebrafish Models of Parkinson's Disease.

Doyle J, Croll R Front Pharmacol. 2022; 13:835827.

PMID: 35370740 PMC: 8965100. DOI: 10.3389/fphar.2022.835827.


Modeling Alzheimer's Disease in .

Alvarez J, Alvarez-Illera P, Santo-Domingo J, Fonteriz R, Montero M Biomedicines. 2022; 10(2).

PMID: 35203497 PMC: 8869312. DOI: 10.3390/biomedicines10020288.